A first-in-human phase I/II trial of SRA737 (a Chk1 Inhibitor) in subjects with advanced cancer
Authors
Plummer, ERKristeleit, RS
Cojocaru, E
Haris, NM
Carter, Louise
Jones, RH
Blagden, SP
Evans, TRJ
Arkenau, HT
Sarker, D
Danson, S
Symeonides, SN
Walter, H
Ocen, J
Randhawa, M
Kowalski, MM
Verdon, I
Dye, A
Banerji, U
Affiliation
Northern Centre for Cancer Care, Newcastle-upon-TyneIssue Date
2019
Metadata
Show full item recordCitation
Plummer ER, Kristeleit RS, Cojocaru E, Haris NM, Carter L, Jones RH, et al. A first-in-human phase I/II trial of SRA737 (a Chk1 Inhibitor) in subjects with advanced cancer. J Clin Oncol. 2019;37(15_suppl):3094-.Journal
Journal of Clinical OncologyDOI
10.1200/JCO.2019.37.15_suppl.3094Additional Links
https://dx.doi.org/ 10.1200/JCO.2019.37.15_suppl.3094Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1200/JCO.2019.37.15_suppl.3094